Cystic Fibrosis Foundation

Insider Reports History

Entity
Company
Location
4550 Montgomery Street, Suite 1100 N, Bethesda, Maryland
Signature
/s/ Ania Howell
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Cystic Fibrosis Foundation:

Stock Role Class Num Shares Value Price $ Report Date Ownership
BiomX Inc. 10%+ Owner Common Stock, par value $0.0001 per share 9.33 M May 15, 2024 Direct
Aridis Pharmaceuticals, Inc. 10%+ Owner Common Stock, par value $0.0001 per share 5.17 M Dec 8, 2022 Direct
BiomX Inc. 10%+ Owner Warrant to purchase common stock 0 May 15, 2024 Direct

Insider Reports Filed by Cystic Fibrosis Foundation

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PHGE BiomX Inc. May 15, 2024 2 $4.78 K 4 May 17, 2024 10%+ Owner
PHGE BiomX Inc. Mar 16, 2024 0 $0 3 Mar 26, 2024 10%+ Owner
ARDS Aridis Pharmaceuticals, Inc. Dec 8, 2022 0 $0 3 Dec 19, 2022 10%+ Owner